“…These alterations occurred in mice aged 5 months, in a mixed‐gender cohort, and were confirmed by RT‐PCR. Myelination delay has been reported on magnetic resonance imaging of human participants with MPS types I and II (Lee et al, 1993), and autopsies have shown patchy areas of demyelination and some, albeit inconsistent, lipid abnormalities in the brain (Clausen et al, 1967; Constantopoulos et al, 1980; Constantopoulos and Dekaban, 1978; Nagashima et al, 1976; Naidoo, 1953) including increased amounts of cholesterol, phospholipid, gangliosides (GM2, GM3, and GD3), ceramide dihexoside in a patient with the severe (Hurler) form of MPS I (Constantopoulos et al, 1980). Savile and colleagues found elevations in the glycerophospholipid bis(monoacylglycero)phosphate in several regions of the brain of MPS I mice, and dietary manipulation of fatty acid intake altered performance of the mice (mixed gender) on behavioral testing (Saville et al, 2017).…”